JP Morgan Upgrades Sotera Health to Neutral, Raises Price Target to $18
JP Morgan analyst Tycho Peterson upgrades Sotera Health (NASDAQ:SHC) from Underweight to Neutral and raises the price target from $6 to $18.
Peering Into Sotera Health’s Recent Short Interest
Sotera Health's (NASDAQ:SHC) short percent of float has fallen 5.05% since its last report. The company recently reported that it has 7.58 million shares sold short, which is 7.71% of all regular shares that are available for trading.
Expert Ratings for Sotera Health
Over the past 3 months, 7 analysts have published their opinion on Sotera Health (NASDAQ:SHC) stock. These analysts…
World Wrestling Entertainment, Bed Bath & Beyond And Other Big Stocks Moving Higher In Wednesday’s Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Dow Rises Over 100 Points; Rayonier Advanced Materials Shares Plunge
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 100 points on Tuesday.
The Dow traded up 0.40% to 33,653.27 while the NASDAQ rose 0.83% to 10,724.37. The S&P 500 also rose, gaining, 0.55% to 3,913.66.
Crude Oil Rises Over 1%; Oak Street Health Shares Spike Higher
U.S. stocks traded slightly higher midway through trading, with the Dow Jones around than 30 points on Tuesday.
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Prenetics Global (NASDAQ:PRE) stock rose 74.7% to $3.25 during Tuesday’s pre-market session. The market value of their…
Why VYNE Therapeutics Shares Are Trading Higher By 82%; Here Are 20 Stocks Moving Premarket
Gainers
VYNE Therapeutics Inc. (NASDAQ: VYNE) rose 82.2% to $0.35 in pre-market trading after the company said first vitiligo patient was dosed in Phase 1a/b clinical trial of novel BET inhibitor VYN201.
Reported Late Monday, Sotera Health Announces Settlement Of Ethylene Oxide Litigation In Illinois; Terms Of The Agreements, Sterigenics Will Pay $408M To Settle The Claims
Sotera Health Company (NASDAQ:SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced that its